FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3150308207> ?p ?o ?g. }

• W3150308207 abstract "Patients with unresectable advanced cutaneous squamous cell carcinoma (cSCC) are generally treated with palliative intent. Immune checkpoint blockade has significant activity in the palliative setting in patients with recurrent or metastatic cSCC. This single arm phase 2 prospective study aims to investigate the combination of curative intent chemoradiation and durvalumab (anti-PD-L1 checkpoint inhibitor) for this patient cohort.Patients with unresectable locally and or regionally advanced pathologically confirmed cSCC (stage III-IVa) deemed fit for CRIO by consensus of the Multidisciplinary meeting will be eligible. In the first stage of a two-stage minimax design, we aim to recruit a total of 15 patients. If fewer than 7 patients achieved a complete response in the first stage, we will conclude the treatment is not more effective than standard treatment. The co-primary endpoints of CRIO are the safety of treatment (acute and late toxicities) and the rate of complete response. Secondary endpoints would include overall survival, progression free survival, and locoregional control. Translational research endpoints including biomarkers (CD73, CD39, PD-1, PD-L1) will also be explored utilising multiplex immunohistochemistry on tumour biopsy samples obtained prior to commencing treatment and during treatment (week 2). In addition, the utility of CXCR-4 PET/CT scan will be explored.CRIO is a novel trial evaluating the combination of curative intent chemoradiotherapy with concurrent and adjuvant durvalumab for patients with unresectable stage III-IVa cSCC.Trial registered with the Australian New Zealand Clinical Trial Registry (ACTRN12618001573246)." @default.
• W3150308207 created "2021-04-13" @default.
• W3150308207 creator A5000040542 @default.
• W3150308207 creator A5003588327 @default.
• W3150308207 creator A5007330428 @default.
• W3150308207 creator A5024113017 @default.
• W3150308207 creator A5029040126 @default.
• W3150308207 creator A5032482843 @default.
• W3150308207 creator A5036046733 @default.
• W3150308207 creator A5042361081 @default.
• W3150308207 creator A5051086683 @default.
• W3150308207 creator A5054520446 @default.
• W3150308207 creator A5066843487 @default.
• W3150308207 creator A5073758435 @default.
• W3150308207 date "2021-04-09" @default.
• W3150308207 modified "2023-10-12" @default.
• W3150308207 title "A prospective study investigating the efficacy and toxicity of definitive ChemoRadiation and ImmunOtherapy (CRIO) in locally and/or regionally advanced unresectable cutaneous squamous cell carcinoma" @default.
• W3150308207 cites W1974187188 @default.
• W3150308207 cites W2010080922 @default.
• W3150308207 cites W2030272844 @default.
• W3150308207 cites W2044554762 @default.
• W3150308207 cites W2049601932 @default.
• W3150308207 cites W2052501998 @default.
• W3150308207 cites W2058026592 @default.
• W3150308207 cites W2062761137 @default.
• W3150308207 cites W2066502054 @default.
• W3150308207 cites W2086238536 @default.
• W3150308207 cites W2086834665 @default.
• W3150308207 cites W2109952478 @default.
• W3150308207 cites W2113661022 @default.
• W3150308207 cites W2114920253 @default.
• W3150308207 cites W2116097769 @default.
• W3150308207 cites W2144174481 @default.
• W3150308207 cites W2145778444 @default.
• W3150308207 cites W2148754315 @default.
• W3150308207 cites W2152061559 @default.
• W3150308207 cites W2153216820 @default.
• W3150308207 cites W2157466346 @default.
• W3150308207 cites W2160141570 @default.
• W3150308207 cites W2168786562 @default.
• W3150308207 cites W2180357767 @default.
• W3150308207 cites W2519184848 @default.
• W3150308207 cites W2564974419 @default.
• W3150308207 cites W2805968856 @default.
• W3150308207 cites W2893824814 @default.
• W3150308207 cites W2978085943 @default.
• W3150308207 cites W4254458243 @default.
• W3150308207 cites W4292318935 @default.
• W3150308207 doi "https://doi.org/10.1186/s13014-021-01795-5" @default.
• W3150308207 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8033693" @default.
• W3150308207 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33836800" @default.
• W3150308207 hasPublicationYear "2021" @default.
• W3150308207 type Work @default.
• W3150308207 sameAs 3150308207 @default.
• W3150308207 citedByCount "10" @default.
• W3150308207 countsByYear W31503082072022 @default.
• W3150308207 countsByYear W31503082072023 @default.
• W3150308207 crossrefType "journal-article" @default.
• W3150308207 hasAuthorship W3150308207A5000040542 @default.
• W3150308207 hasAuthorship W3150308207A5003588327 @default.
• W3150308207 hasAuthorship W3150308207A5007330428 @default.
• W3150308207 hasAuthorship W3150308207A5024113017 @default.
• W3150308207 hasAuthorship W3150308207A5029040126 @default.
• W3150308207 hasAuthorship W3150308207A5032482843 @default.
• W3150308207 hasAuthorship W3150308207A5036046733 @default.
• W3150308207 hasAuthorship W3150308207A5042361081 @default.
• W3150308207 hasAuthorship W3150308207A5051086683 @default.
• W3150308207 hasAuthorship W3150308207A5054520446 @default.
• W3150308207 hasAuthorship W3150308207A5066843487 @default.
• W3150308207 hasAuthorship W3150308207A5073758435 @default.
• W3150308207 hasBestOaLocation W31503082071 @default.
• W3150308207 hasConcept C121608353 @default.
• W3150308207 hasConcept C126322002 @default.
• W3150308207 hasConcept C143998085 @default.
• W3150308207 hasConcept C146357865 @default.
• W3150308207 hasConcept C151730666 @default.
• W3150308207 hasConcept C203092338 @default.
• W3150308207 hasConcept C2777701055 @default.
• W3150308207 hasConcept C2777742743 @default.
• W3150308207 hasConcept C2778424827 @default.
• W3150308207 hasConcept C2780030458 @default.
• W3150308207 hasConcept C509974204 @default.
• W3150308207 hasConcept C535046627 @default.
• W3150308207 hasConcept C71924100 @default.
• W3150308207 hasConcept C86803240 @default.
• W3150308207 hasConceptScore W3150308207C121608353 @default.
• W3150308207 hasConceptScore W3150308207C126322002 @default.
• W3150308207 hasConceptScore W3150308207C143998085 @default.
• W3150308207 hasConceptScore W3150308207C146357865 @default.
• W3150308207 hasConceptScore W3150308207C151730666 @default.
• W3150308207 hasConceptScore W3150308207C203092338 @default.
• W3150308207 hasConceptScore W3150308207C2777701055 @default.
• W3150308207 hasConceptScore W3150308207C2777742743 @default.
• W3150308207 hasConceptScore W3150308207C2778424827 @default.
• W3150308207 hasConceptScore W3150308207C2780030458 @default.
• W3150308207 hasConceptScore W3150308207C509974204 @default.
• W3150308207 hasConceptScore W3150308207C535046627 @default.
• W3150308207 hasConceptScore W3150308207C71924100 @default.
• W3150308207 hasConceptScore W3150308207C86803240 @default.
• W3150308207 hasFunder F4320323165 @default.

• next